Evaluating Weight Loss Outcomes in Adults With Overweight or Obesity Using Weight Management Medications
ClinicalTrials.gov Studies
Summary
NIH registered NCT07551193, an observational retrospective study evaluating weight loss outcomes in adults with overweight or obesity using weight management medications. The study will assess weight change at 12 months, improvements in blood sugar and cholesterol levels, and medication safety and tolerability using existing medical records and pharmacy claims data. No new interventions will be performed; all data derives from routine clinical care.
“The goal of this observational study is to evaluate weight loss outcomes in adults with overweight or obesity using weight management medications.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
NIH registered a new observational study (NCT07551193) on ClinicalTrials.gov titled 'Evaluating Weight Loss Outcomes in Patients With Overweight or Obesity.' The study is retrospective, using existing medical records and pharmacy claims data, with no prospective enrollment of participants. Primary endpoints include 12-month weight change, metabolic marker improvements (blood sugar, cholesterol), and safety/tolerability assessments. This study registration represents routine cataloguing of clinical research activity rather than a regulatory action or compliance requirement. Researchers, pharmaceutical manufacturers, and healthcare providers may find this registry entry useful for identifying ongoing real-world evidence generation in the weight management medication space.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Evaluating Weight Loss Outcomes in Patients With Overweight or Obesity
Observational NCT07551193 Kind: OBSERVATIONAL Apr 24, 2026
Abstract
The goal of this observational study is to evaluate weight loss outcomes in adults with overweight or obesity using weight management medications. The main questions it aims to answer are: (1) How much weight do patients lose after 12 months? (2) Do blood sugar and cholesterol levels improve? (3) How safe and tolerable are these medications? This is a retrospective study using existing medical records and pharmacy claims. Participants will not be asked to do anything new; all data will be collected from routine clinical care.
Conditions: Overweight and Obesity
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.